Although the data are not univocal (Page et al., 1978; Dupont et al., 1985), several studies suggest that women with gross cystic disease have a greater risk of developing breast cancer (Haagensen et al., 1981) . These cysts are lined by apocrine or flattened epithelium, the former being at greater risk of neoplastic transformation (Haagensen et al., 1981; Dixon et al., 1985) . Because of these observations, breast cyst fluid (BCF) which is easily obtainable from cysts by aspiration, has been extensively investigated in order to identify specific biochemical features related to cyst evolution (Bradlow et al., 1981; Jaspar et al., 1980; Boccardo et al., 1988; Battaglia et al., 1989; Hamed et al., 1990; Lai et al., 1990) . The concentrations of electrolytes in BCF has been shown to be correlated with the pathohistology of the breast (Dixon et al., 1985) . Moreover we (Battaglia et al., 1989) and others (Jaspar et al., 1980; Boccardo et al., 1988; Hamed et al., 1990; Todaro et al., 1980) reported that BCF contain large amounts of Epidermal Growth Factor (EGF), which has a mitogenic effect on normal and neoplastic breast cells in vitro and seems to be involved in the autocrine regulation of breast cancer in vivo (Todaro et al., 1980; Osborne et al., 1980; Taketani et al., 1983) . The finding that higher EGF concentrations are present in apocrine than flattened cysts have suggested that this growth factor may be involved in mammary carcinogenesis (Boccardo et al., 1988; Battaglia et al., 1989; Hamed et al., 1990; Lai et al., 1990) . Garcia et al. (1986) reported that BCF also contain varying concentrations of a Mr 52,000 (52K) secreted protein induced by oestrogen in MCF-7 cells (Westley et al., 1979) . This protein has been identified as pro-Cath-D, a proteolytic enzyme which displays a mitogenic effect in vitro (Vignon et al., 1986; Morisset et al., 1986; Briozzo et al., 1988 Haagensen et al. (1981) and the size of cysts was determined by ultrasonography (General Electric RT 3600). Cystic volume was measured according to the formula for an ovoid sphere n x 1/6 (length x width x depth). The cyst fluid aspirates were centrifuged at 2,000g at 4'C. The cellular material was stained by PAP technique and by periodic acid-shift for cytologic examination. The supranatant was aliquoted and stored at -20'C until the assay.
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Cath-D concentration was assayed using a solid phase two site immunoradiometric assay (CIS bioindustries, Gift-surYvette, France) in which the first monoclonal antibody (D7E3) is coated on the ELISA solid phase and the second one, M1G8, radiolabelled with 125I is used as a tracer (Brouillet et al., 1990; Scambia et al., 1991) . For the Cath-D assay, cytosol protein concentration measured by the Bradford method (Bradford et al., 1976) was reset to about 1 mg ml-I before the assay. Cytosols were then diluted 1/40 and 1/80 with the diluent contained in the kit. Radioactivity was measured in a 'y-counter for 1 min. Intra-and inter-assay variations were 6.4% and 8.5%, respectively.
The EGF assay was performed by a radio-receptor assay based on the competitive protein binding, using membrane receptor particles as the binding protein and an "25I labelled EGF peptide (Amersham Int, Holland) (Battaglia et al., 1989 (Battaglia et al., 1989) and others (Boccardo et al., 1988; Hamed et al., 1990; Lai et al., 1990) (Vignon et al., 1986 ) and a proteolytic effect on extracellular matrix after its autoactivation at acidic pH (Briozzo et al., 1988) . In breast cancer, a high cytosolic concentration of Cath D is associated with a shorter relapse-free survival (Brouillet et al., 1990) .
Results reported here indicate that ranging concentrations of Cath D are present in BCF. This is a further demonstration that BCF contain substances which may be involved in the autocrine and/or paracrine regulation of the proliferation of breast cyst epithelium (Jaspar et al., 1980; Boccardo et al., 1988; Battaglia et al., 1989; Wang et al., 1989; Hamed et al., 1990; Lai et al., 1990) .
The most interesting finding of this study is that Cath D concentrations were higher in apocrine than flattened cysts, since patients with apocrine cysts are those with higher risk of developing breast cancer. This is consistent with a previous study by Garcia et al. (1986) who reported that the immunohistochemical evaluation of 52K is a potential tissue marker for distinguishing high-(proliferative) from low-risk (non proliferative) benign breast disease.
Interestingly, the values of EGF/x-TGF showed a distribution similar to that of Cath D. This finding was in keeping with our previous study (Battaglia et al., 1989) and with three other reports (Boccardo et al., 1988; Hamed et al., 1990; Lai et al., 1990) . It can be suggested that an increased production of mitogenic substances such as Cath D and EGF/a-TGF may be associated with the early stages of mammary carcinogenesis. It is also conceivable that Cath D and EGF may cooperate in the promotion of breast cell proliferation. As for other proteases, Cath D may act indirectly by releasing growth factors, such as ox-TGF from precursors or from extracellular matrix and/or by activating growth factor receptors (Derynck et al., 1984; Lawrence et al., 1985) .
A positive correlation has been found between intracystic concentrations of Cath D and EGF/a-TGF. This is in agreement with the finding that in human breast and endometrial cancer cells Cath D is regulated at the mRNA level by EGF (Cavailles et al., 1988) . Alternatively it is possible that a common stimulus might be responsible for the elevating levels of Cath D and EGF/a-TGF. As a matter of fact in .0 *0 00 *o human breast cancer cells oestrogen modulate the secretion of Cath D (Westley et al., 1979; Vignon et al., 1986; Morisset et al., 1986 ) and a-TGF (Dickson et al., 1986) . The finding of higher levels of both substances in BCF in premenopausal women with respect to postmenopausal women, suggest that sex steroid hormones might be involved in the growth peptide production by cystic epithelium of the breast.
In conclusion, our study indicates that BCF contains Cath D and that this enzyme, together with EGF/a-TGF may have a role in the proliferative pathology of the breast. The solution to this problem will come from a prospective study of patients with gross cystic disease.
